Health ROI as a measure of misalignment of biomedical needs and resources : Nature Biotechnology : Nature Publishing Group

Health ROI as a measure of misalignment of…needs & resources by @arzhetsky See funding decisions like stock trades

QT:{{"In a recently published letter to Nature Biotechnology, Lixia Yao,
IGSB core faculty Andrey Rzhetsky and colleagues dissect the decisions
made in funding choices. His team compares these choices by funding
agencies to trades in a financial market. In this communication, they
expand on the idea that there exists an imbalance between health needs
and biomedical research investment.

In order to fairly examine the relationship between biomedical need
and biomedical research, they validated a new, insurance based measure
of health burden that enables automatic evaluation of burden and
research investment for many more diseases than have been previously
assessed. "

Tags: ,

Comments are closed.